13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0000935836-23-000688
Total Value
$301.0M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | QUIDELORTHO CORP | QDEL | 658,794 | $48.1M | 15.98% |
| 2 | EVOLUS INC | EOLS | 5,179,004 | $47.3M | 15.72% |
| 3 | AMYLYX PHARMACEUTICALS INC | AMLX | 2,515,868 | $46.1M | 15.30% |
| 4 | ADMA BIOLOGICS INC | ADMA | 9,104,275 | $32.6M | 10.83% |
| 5 | GALAPAGOS NV-SPON ADR | GLPGF | 802,544 | $27.7M | 9.21% |
| 6 | ALIMERA SCIENCES INC | 016259202 | 3,983,686 | $12.3M | 4.10% |
| 7 | MAXCYTE INC | MXCT | 3,761,640 | $11.7M | 3.90% |
| 8 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,915,372 | $11.0M | 3.65% |
| 9 | GAMIDA CELL LTD | M47364100 | 7,965,865 | $8.2M | 2.73% |
| 10 | ATYR PHARMA INC | ATYR | 4,626,624 | $7.3M | 2.43% |
| 11 | SCYNEXIS INC | SCYX | 2,852,599 | $6.5M | 2.16% |
| 12 | XOMA CORP | XOMAP | 436,602 | $6.2M | 2.04% |
| 13 | X4 PHARMACEUTICALS INC | XFOR | 5,273,685 | $5.7M | 1.91% |
| 14 | ATEA PHARMACEUTICALS INC | AVIR | 1,720,000 | $5.2M | 1.71% |
| 15 | REZOLUTE INC | RZLT | 3,072,476 | $4.1M | 1.35% |
| 16 | TELA BIO INC | TELA | 491,919 | $3.9M | 1.31% |
| 17 | EXAGEN INC | XGN | 1,203,491 | $2.9M | 0.97% |
| 18 | IO BIOTECH INC | IOBT | 1,975,308 | $2.8M | 0.93% |
| 19 | GOSSAMER BIO INC | GOSS | 3,339,405 | $2.8M | 0.92% |
| 20 | DELCATH SYSTEMS INC | DCTH | 686,240 | $2.8M | 0.92% |
| 21 | ASSERTIO HOLDINGS INC | ASRT | 951,197 | $2.4M | 0.81% |
| 22 | VANDA PHARMACEUTICALS INC | VNDA | 477,903 | $2.1M | 0.69% |
| 23 | AYTU BIOPHARMA INC | AYTU | 472,369 | $1.3M | 0.42% |